Attached files

file filename
10-Q - TAMIR BIOTECHNOLOGY, INC. APRIL 30, 2013 - Tamir Biotechnology, Inc.acelfor10q130430.htm
EX-31.1 - EXHIBIT 31.1 - Tamir Biotechnology, Inc.exhibit31_1.htm
EX-31.2 - EXHIBIT 31.2 - Tamir Biotechnology, Inc.exhibit31_2.htm

EXHIBIT 32

TAMIR BIOTECHNOLOGY, INC.

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18,

UNITED STATES CODE)

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Tamir Biotechnology, Inc. (the “Company”), does hereby certify, to the best of his knowledge and belief that:

 

(1) The Quarterly Report on Form 10-Q for the period ended April 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

June 10, 2013
 
 
/s/ JAMIE SULLEY
President
 
June 10, 2013
 
 
/s/ JOANNE BARSA
Chief Financial Officer